| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | arylsulfatase activity | 2.53e-05 | 14 | 84 | 3 | GO:0004065 | |
| GeneOntologyMolecularFunction | sulfuric ester hydrolase activity | 4.68e-05 | 17 | 84 | 3 | GO:0008484 | |
| GeneOntologyMolecularFunction | dopamine beta-monooxygenase activity | 5.23e-05 | 3 | 84 | 2 | GO:0004500 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen | 1.73e-04 | 5 | 84 | 2 | GO:0016715 | |
| GeneOntologyBiologicalProcess | ethanolamine-containing compound metabolic process | 7.12e-06 | 10 | 82 | 3 | GO:0042439 | |
| GeneOntologyBiologicalProcess | octopamine metabolic process | 4.67e-05 | 3 | 82 | 2 | GO:0046333 | |
| GeneOntologyBiologicalProcess | octopamine biosynthetic process | 4.67e-05 | 3 | 82 | 2 | GO:0006589 | |
| Domain | Sulfatase_CS | 4.23e-05 | 16 | 81 | 3 | IPR024607 | |
| Domain | SULFATASE_1 | 5.11e-05 | 17 | 81 | 3 | PS00523 | |
| Domain | SULFATASE_2 | 5.11e-05 | 17 | 81 | 3 | PS00149 | |
| Domain | Sulfatase | 6.12e-05 | 18 | 81 | 3 | PF00884 | |
| Domain | Sulfatase_N | 6.12e-05 | 18 | 81 | 3 | IPR000917 | |
| Domain | VWA | 1.02e-04 | 56 | 81 | 4 | PF00092 | |
| Domain | Alkaline_phosphatase_core | 3.24e-04 | 31 | 81 | 3 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 3.24e-04 | 31 | 81 | 3 | IPR017849 | |
| Domain | - | 3.24e-04 | 31 | 81 | 3 | 3.40.720.10 | |
| Domain | VWFA | 4.44e-04 | 82 | 81 | 4 | PS50234 | |
| Domain | VWA | 4.87e-04 | 84 | 81 | 4 | SM00327 | |
| Domain | VWF_A | 9.04e-04 | 99 | 81 | 4 | IPR002035 | |
| Domain | Integrin_alpha | 9.96e-04 | 11 | 81 | 2 | PF00357 | |
| Domain | CUB | 1.25e-03 | 49 | 81 | 3 | PF00431 | |
| Domain | CUB | 1.33e-03 | 50 | 81 | 3 | SM00042 | |
| Domain | - | 1.49e-03 | 52 | 81 | 3 | 2.60.120.290 | |
| Domain | CUB | 1.57e-03 | 53 | 81 | 3 | PS01180 | |
| Domain | CUB_dom | 1.94e-03 | 57 | 81 | 3 | IPR000859 | |
| Domain | Integrin_alpha_C_CS | 2.14e-03 | 16 | 81 | 2 | IPR018184 | |
| Domain | Integrin_alpha-2 | 2.72e-03 | 18 | 81 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 2.72e-03 | 18 | 81 | 2 | PF08441 | |
| Domain | Integrin_alpha | 2.72e-03 | 18 | 81 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 2.72e-03 | 18 | 81 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 3.03e-03 | 19 | 81 | 2 | IPR013519 | |
| Domain | PA | 3.03e-03 | 19 | 81 | 2 | PF02225 | |
| Domain | PA_domain | 3.03e-03 | 19 | 81 | 2 | IPR003137 | |
| Domain | Int_alpha | 3.03e-03 | 19 | 81 | 2 | SM00191 | |
| Domain | RCC1 | 3.36e-03 | 20 | 81 | 2 | PF00415 | |
| Domain | FRI | 3.36e-03 | 20 | 81 | 2 | SM00063 | |
| Domain | RCC1_1 | 3.70e-03 | 21 | 81 | 2 | PS00625 | |
| Domain | RCC1_2 | 3.70e-03 | 21 | 81 | 2 | PS00626 | |
| Domain | - | 3.70e-03 | 21 | 81 | 2 | 1.10.2000.10 | |
| Domain | RCC1_3 | 3.70e-03 | 21 | 81 | 2 | PS50012 | |
| Domain | AA-permease/SLC12A_dom | 4.06e-03 | 22 | 81 | 2 | IPR004841 | |
| Domain | Reg_chr_condens | 4.06e-03 | 22 | 81 | 2 | IPR000408 | |
| Domain | AA_permease | 4.06e-03 | 22 | 81 | 2 | PF00324 | |
| Domain | - | 4.06e-03 | 22 | 81 | 2 | 2.130.10.30 | |
| Domain | FG_GAP | 4.06e-03 | 22 | 81 | 2 | PS51470 | |
| Domain | RCC1/BLIP-II | 4.43e-03 | 23 | 81 | 2 | IPR009091 | |
| Domain | FG-GAP | 4.82e-03 | 24 | 81 | 2 | PF01839 | |
| Domain | Frizzled_dom | 4.82e-03 | 24 | 81 | 2 | IPR020067 | |
| Domain | FG-GAP | 4.82e-03 | 24 | 81 | 2 | IPR013517 | |
| Domain | FZ | 4.82e-03 | 24 | 81 | 2 | PS50038 | |
| Domain | Fz | 4.82e-03 | 24 | 81 | 2 | PF01392 | |
| Domain | Integrin_dom | 5.22e-03 | 25 | 81 | 2 | IPR032695 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | DPEP1 PLB1 ABCA1 ARSJ STS DGAT2 ACHE SLC27A1 INSIG2 PLA2G4F FUT1 CUBN ARSI | 9.29e-06 | 757 | 58 | 13 | M27451 |
| Pathway | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | 1.84e-05 | 13 | 58 | 3 | M663 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 9.27e-05 | 58 | 58 | 4 | M576 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION | 1.13e-04 | 61 | 58 | 4 | M26993 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 36789964 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9598326 | ||
| Pubmed | The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface. | 5.90e-06 | 2 | 85 | 2 | 22927462 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21945601 | ||
| Pubmed | Protein phosphatase 4 plays dual roles during cell proliferation. | 5.90e-06 | 2 | 85 | 2 | 27041735 | |
| Pubmed | Evidence for genetic modifiers other than filaggrin mutations in X-linked ichthyosis. | 5.90e-06 | 2 | 85 | 2 | 20149601 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15073167 | ||
| Pubmed | Association of NOTCH4 and ACHE gene polymorphism in Alzheimer's disease of Gujarat cohort. | 5.90e-06 | 2 | 85 | 2 | 37544578 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.36e-05 | 211 | 85 | 6 | 24097068 | |
| Pubmed | 1.56e-05 | 20 | 85 | 3 | 23824729 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 27413011 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 26526492 | ||
| Pubmed | Molecular cloning and initial characterization of three novel human sulfatases. | 1.77e-05 | 3 | 85 | 2 | 16500042 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 26134560 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 15210787 | ||
| Pubmed | The structure and interactions of the proline-rich domain of ASPP2. | 5.87e-05 | 5 | 85 | 2 | 18448430 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 37781399 | ||
| Pubmed | CD11c regulates hematopoietic stem and progenitor cells under stress. | 5.87e-05 | 5 | 85 | 2 | 33351105 | |
| Pubmed | The ER-Localized Protein DFCP1 Modulates ER-Lipid Droplet Contact Formation. | 8.80e-05 | 6 | 85 | 2 | 30970241 | |
| Pubmed | Protein phosphatase X interacts with c-Rel and stimulates c-Rel/nuclear factor kappaB activity. | 8.80e-05 | 6 | 85 | 2 | 9837938 | |
| Pubmed | 1.21e-04 | 39 | 85 | 3 | 21347282 | ||
| Pubmed | Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. | 1.23e-04 | 7 | 85 | 2 | 16174644 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 20797629 | ||
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 1.74e-04 | 44 | 85 | 3 | 27534441 | |
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 8824813 | ||
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 22990020 | ||
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 33282727 | ||
| Pubmed | FBXO34 promotes latent HIV-1 activation by post-transcriptional modulation. | 3.20e-04 | 11 | 85 | 2 | 36285453 | |
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 20852008 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 4.14e-04 | 552 | 85 | 7 | 10737800 | |
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 12231349 | ||
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 16870193 | ||
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 20563599 | ||
| Pubmed | Expression patterns of sulfatase genes in the developing mouse embryo. | 4.52e-04 | 13 | 85 | 2 | 20503373 | |
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 11239002 | ||
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 5.17e-04 | 410 | 85 | 6 | 25814554 | |
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 38327785 | ||
| Pubmed | 5.72e-04 | 418 | 85 | 6 | 35338135 | ||
| Pubmed | 6.07e-04 | 15 | 85 | 2 | 20031603 | ||
| Pubmed | 6.07e-04 | 15 | 85 | 2 | 20160193 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 26263173 | ||
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 7.74e-04 | 73 | 85 | 3 | 32347575 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 8.75e-04 | 1021 | 85 | 9 | 26760575 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 9.56e-04 | 307 | 85 | 5 | 37499664 | |
| Pubmed | Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. | 9.83e-04 | 19 | 85 | 2 | 21060863 | |
| Pubmed | 9.83e-04 | 19 | 85 | 2 | 12721789 | ||
| Pubmed | 1.09e-03 | 20 | 85 | 2 | 11322959 | ||
| Pubmed | 1.20e-03 | 21 | 85 | 2 | 12840015 | ||
| Pubmed | 1.32e-03 | 22 | 85 | 2 | 25331947 | ||
| Pubmed | 1.32e-03 | 22 | 85 | 2 | 28890335 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.51e-03 | 1105 | 85 | 9 | 35748872 | |
| Pubmed | 1.52e-03 | 201 | 85 | 4 | 25192599 | ||
| Pubmed | The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA. | 1.57e-03 | 24 | 85 | 2 | 24798327 | |
| Pubmed | 1.57e-03 | 24 | 85 | 2 | 34983926 | ||
| Pubmed | 1.71e-03 | 25 | 85 | 2 | 19092943 | ||
| Pubmed | 1.98e-03 | 533 | 85 | 6 | 25544563 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.99e-03 | 27 | 85 | 2 | 31541017 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 2.05e-03 | 218 | 85 | 4 | 35831895 | |
| Pubmed | 2.09e-03 | 103 | 85 | 3 | 11752456 | ||
| Pubmed | 2.09e-03 | 730 | 85 | 7 | 34857952 | ||
| Pubmed | 2.21e-03 | 1168 | 85 | 9 | 19946888 | ||
| Pubmed | 2.30e-03 | 29 | 85 | 2 | 20972250 | ||
| Cytoband | 7q22 | 4.93e-05 | 38 | 85 | 3 | 7q22 | |
| Cytoband | 16p11.2 | 4.52e-04 | 191 | 85 | 4 | 16p11.2 | |
| GeneFamily | Sulfatases | 2.74e-05 | 18 | 60 | 3 | 410 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-06 | 180 | 85 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 180 | 85 | 6 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 180 | 85 | 6 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-06 | 186 | 85 | 6 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-06 | 191 | 85 | 6 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 191 | 85 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-06 | 193 | 85 | 6 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-06 | 198 | 85 | 6 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 2.21e-06 | 198 | 85 | 6 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-06 | 199 | 85 | 6 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-06 | 200 | 85 | 6 | 73bfdf068a8ecbefc1e6afe9686df73658ee042f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.53e-06 | 127 | 85 | 5 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.89e-06 | 70 | 85 | 4 | b159435487b90331d2d276f182fc8aedf88d612c | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Il33_(Il33)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.89e-06 | 70 | 85 | 4 | 7e09547b73789d789c3c464689f7998445830238 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.89e-06 | 70 | 85 | 4 | b486f7fe68743e3385809cfd64512da2f31074df | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Il33_(Il33)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.89e-06 | 70 | 85 | 4 | 8ee9c9c78eec9dc0cec364ee7c9bc6f34d37de76 | |
| ToppCell | Control-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 1.19e-05 | 155 | 85 | 5 | 4b9369b203a4d7071c56d3d8e6b450e9a0121c41 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.71e-05 | 167 | 85 | 5 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 171 | 85 | 5 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-05 | 171 | 85 | 5 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 174 | 85 | 5 | 95464817adef5ad2038bbf542f315756b7ad862e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_proximal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.33e-05 | 178 | 85 | 5 | 9534c4f4e950bb1498c1737ca1713e7f37d0aff2 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 179 | 85 | 5 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-05 | 180 | 85 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 181 | 85 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 181 | 85 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 181 | 85 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 181 | 85 | 5 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 181 | 85 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 181 | 85 | 5 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.59e-05 | 182 | 85 | 5 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.59e-05 | 182 | 85 | 5 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 182 | 85 | 5 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.66e-05 | 183 | 85 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 2.80e-05 | 185 | 85 | 5 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 185 | 85 | 5 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 188 | 85 | 5 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.02e-05 | 188 | 85 | 5 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-05 | 189 | 85 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-05 | 190 | 85 | 5 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-05 | 190 | 85 | 5 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.18e-05 | 190 | 85 | 5 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-05 | 190 | 85 | 5 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.26e-05 | 191 | 85 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | facs-Aorta-Heart-18m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 191 | 85 | 5 | 6242f83acaf1714e9c1771a832cb67674b19e96d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.26e-05 | 191 | 85 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.26e-05 | 191 | 85 | 5 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 3.26e-05 | 191 | 85 | 5 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 192 | 85 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 192 | 85 | 5 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 192 | 85 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 192 | 85 | 5 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 192 | 85 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 192 | 85 | 5 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 192 | 85 | 5 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 193 | 85 | 5 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-05 | 193 | 85 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-05 | 193 | 85 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 193 | 85 | 5 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-05 | 193 | 85 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 193 | 85 | 5 | 2d891c00b8f0aace17d4c300b63e2341dcffa199 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.42e-05 | 193 | 85 | 5 | fe9720185929ef849edd1b8eb4854306b392e5a2 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.42e-05 | 193 | 85 | 5 | e27885a9e1a2a3e165c5366d4cfcda05c5454483 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-05 | 194 | 85 | 5 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.51e-05 | 194 | 85 | 5 | c9e589fe7df6a9b377654581a2aebb607cbb03b9 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.51e-05 | 194 | 85 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 194 | 85 | 5 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.51e-05 | 194 | 85 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-05 | 194 | 85 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Aerocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.51e-05 | 194 | 85 | 5 | 54b7126b83f7482227aeaea065f504b65fa34bfe | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-05 | 194 | 85 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-05 | 195 | 85 | 5 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.60e-05 | 195 | 85 | 5 | dfc5da514fb34a2c318a5c4c61f44049fa43960e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 196 | 85 | 5 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.69e-05 | 196 | 85 | 5 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 196 | 85 | 5 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.78e-05 | 197 | 85 | 5 | 9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-GABAergic_neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.78e-05 | 197 | 85 | 5 | 21f3ef7c3c10b4e3adde431097dfdcd513c74a95 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.87e-05 | 198 | 85 | 5 | 81c4c5377d0901ee9594424f08b0e4101686c850 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-05 | 198 | 85 | 5 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-05 | 198 | 85 | 5 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-05 | 199 | 85 | 5 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | (5)_Epi_suprabasal|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.96e-05 | 199 | 85 | 5 | e1d0fd71b2f3925d02638413f2155db009f103d9 | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-05 | 199 | 85 | 5 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-05 | 199 | 85 | 5 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-05 | 199 | 85 | 5 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-05 | 199 | 85 | 5 | a538da095ba996ee96e263442cf5b6ba9178f3d4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-05 | 199 | 85 | 5 | 4032f03a4165f5f2a90ef1d8315cc743ce9075bb | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.96e-05 | 199 | 85 | 5 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-05 | 199 | 85 | 5 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-05 | 199 | 85 | 5 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-05 | 199 | 85 | 5 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.96e-05 | 199 | 85 | 5 | cfe6f881a86607544e1413ef38e4b6797ef1a61c | |
| Drug | diisopropylfluorophosphate | 2.34e-06 | 321 | 82 | 9 | CID000005936 | |
| Disease | fatty acid measurement | 2.92e-05 | 436 | 82 | 8 | EFO_0005110 | |
| Disease | choline measurement | 3.19e-05 | 130 | 82 | 5 | EFO_0010116 | |
| Disease | bombesin receptor-activated protein C6orf89 measurement | 7.59e-05 | 5 | 82 | 2 | EFO_0801428 | |
| Disease | phosphatidylcholine measurement | 1.43e-04 | 284 | 82 | 6 | EFO_0010226 | |
| Disease | ductal carcinoma in situ (is_implicated_in) | 1.59e-04 | 7 | 82 | 2 | DOID:0060074 (is_implicated_in) | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.03e-04 | 303 | 82 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | premature menopause (biomarker_via_orthology) | 2.11e-04 | 8 | 82 | 2 | DOID:10787 (biomarker_via_orthology) | |
| Disease | total lipids in lipoprotein particles measurement | 3.27e-04 | 48 | 82 | 3 | EFO_0022309 | |
| Disease | Papillary Renal Cell Carcinoma | 4.55e-04 | 128 | 82 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.55e-04 | 128 | 82 | 4 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.55e-04 | 128 | 82 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.55e-04 | 128 | 82 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.55e-04 | 128 | 82 | 4 | C1266044 | |
| Disease | phospholipid measurement | 6.37e-04 | 140 | 82 | 4 | EFO_0004639 | |
| Disease | HDL cholesterol change measurement, physical activity | 6.95e-04 | 62 | 82 | 3 | EFO_0003940, EFO_0007805 | |
| Disease | Malignant neoplasm of breast | 7.79e-04 | 1074 | 82 | 10 | C0006142 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 7.85e-04 | 148 | 82 | 4 | C0279702 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 8.88e-04 | 153 | 82 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 8.88e-04 | 153 | 82 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | complex trait | 9.66e-04 | 271 | 82 | 5 | EFO_0010578 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.01e-03 | 274 | 82 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.05e-03 | 276 | 82 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | Amphetamine-Related Disorders | 1.21e-03 | 75 | 82 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 1.21e-03 | 75 | 82 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 1.21e-03 | 75 | 82 | 3 | C0236804 | |
| Disease | skin sensitivity to sun | 1.27e-03 | 19 | 82 | 2 | EFO_0004795 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.27e-03 | 19 | 82 | 2 | DOID:2876 (is_marker_for) | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 1.27e-03 | 19 | 82 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | free cholesterol in large HDL measurement | 1.40e-03 | 79 | 82 | 3 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 1.46e-03 | 80 | 82 | 3 | EFO_0021900 | |
| Disease | epilepsy (biomarker_via_orthology) | 1.55e-03 | 21 | 82 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 1.55e-03 | 21 | 82 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 1.55e-03 | 21 | 82 | 2 | OBA_2045156 | |
| Disease | saturated fatty acids to total fatty acids percentage | 1.55e-03 | 21 | 82 | 2 | EFO_0022305 | |
| Disease | triacylglycerol 48:3 measurement | 1.70e-03 | 22 | 82 | 2 | EFO_0010406 | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.73e-03 | 85 | 82 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | hair color | 1.77e-03 | 311 | 82 | 5 | EFO_0003924 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 1.86e-03 | 23 | 82 | 2 | OBA_2045158 | |
| Disease | arginine measurement | 1.86e-03 | 23 | 82 | 2 | EFO_0020990 | |
| Disease | HDL cholesterol change measurement | 2.02e-03 | 24 | 82 | 2 | EFO_0007805 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 2.03e-03 | 321 | 82 | 5 | EFO_0004612, EFO_0004639 | |
| Disease | lipid measurement, lipoprotein measurement | 2.04e-03 | 90 | 82 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | complement C4b measurement | 2.20e-03 | 25 | 82 | 2 | EFO_0008092 | |
| Disease | vitamin D measurement | 2.48e-03 | 336 | 82 | 5 | EFO_0004631 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.68e-03 | 99 | 82 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | triglyceride measurement, alcohol drinking | 2.68e-03 | 99 | 82 | 3 | EFO_0004329, EFO_0004530 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WGTSKDFGISGFRFG | 391 | Q4AC99 | |
| LVWIYGGGFYSGASS | 146 | P22303 | |
| KGPDGLSFYGDRWSG | 616 | Q9BWT7 | |
| QLYWAKGTGFGTGST | 4286 | Q9NR09 | |
| GSGGATKYTIYWGFR | 116 | Q5T035 | |
| GLFYIHGGGWCVGSA | 106 | P22760 | |
| GTYWEGGVRGLGFVH | 316 | Q5FYB1 | |
| WVNEFRYGGFSLGVS | 1526 | O95477 | |
| GGGIFFSSGARWRAA | 111 | Q8TAV3 | |
| SGGWAEFTALYGDGA | 141 | Q92843 | |
| GWSRLAGATYRGVYG | 511 | Q3MIX3 | |
| YIIGGAAVARAWSGY | 126 | O43246 | |
| WSGGRSGRSGSFIYQ | 1106 | P20930 | |
| TGIVSWGIGCSRGYG | 671 | P00736 | |
| DSQKRVFSWGFGGYG | 346 | Q9P258 | |
| VFSWGFGGYGRLGHA | 351 | Q9P258 | |
| GTGGRGFLLWYSGRA | 136 | Q15113 | |
| GFLLWYSGRATSGTE | 141 | Q15113 | |
| VLGAVGSFTWSGGAF | 366 | P20702 | |
| RWGLVTGAYVAGFFS | 141 | Q8NGE9 | |
| YITGWGDTGRAYSRT | 766 | P56730 | |
| YTGPSSSGRFAGREW | 271 | O43639 | |
| GTTFIGYVGLWTGQS | 171 | Q02083 | |
| SSGELYTWGLGEYGR | 3116 | O95714 | |
| ARIGSGKFSLSGGYW | 631 | P51812 | |
| GTYWEGGIRAVGFVH | 346 | Q5FYB0 | |
| YVILGGHRDSWVFGG | 371 | Q04609 | |
| WTGDVGGAGTSARVY | 821 | Q8IVV2 | |
| GTLFIWASGNGGLHY | 291 | Q6UW60 | |
| GWGDIGYSFVVGSDG | 441 | Q96PD5 | |
| AYALSPFSASGGWGR | 56 | Q9Y4A8 | |
| FAFLWAGGRASYGVS | 316 | Q00839 | |
| LGWAFYTAIGGTVLT | 181 | Q6ZUX7 | |
| WKYSRGAGLGFSTAP | 426 | Q1ED39 | |
| WGVSLAGSGFGRYSV | 21 | Q9UN67 | |
| WTFDRSRSGFGLGVG | 146 | Q9Y5U4 | |
| AGSGLSFLEWYRGSV | 576 | Q68DD2 | |
| LGAVGSFSWSGGAFL | 366 | Q13349 | |
| WFVYGCGGELSGATG | 1386 | O60494 | |
| GGGSLYSDVSTGLTW | 661 | Q9H461 | |
| NSYTAGGLFKESWRG | 871 | Q9P2Q2 | |
| PGSSYWERSSFGGVQ | 471 | O75054 | |
| GSIINGADWYSFTGG | 441 | Q66K79 | |
| SSGWERVFGTYFRVG | 1741 | Q96HP0 | |
| AGGSTRSGHVLYSGW | 31 | Q2WGN9 | |
| AQGFLLSLAFYGWTG | 301 | P51810 | |
| GATAYRLAWGRSEGG | 801 | Q02388 | |
| TVGFGSGLHGWAFTL | 211 | P13639 | |
| YGRWAVVSGATDGIG | 66 | Q3SXM5 | |
| GFIFEGGTRCGYWAG | 166 | Q18PE1 | |
| LRAGFVGGQFWSVYT | 71 | P16444 | |
| VGTAYWALAGSIGGL | 191 | Q8IZD6 | |
| GRGTSTYDGFGLAWA | 751 | P43246 | |
| GRGLFSSDTWGLVPY | 316 | Q96PD7 | |
| WGVSLAGSGFGRYSV | 21 | Q9Y5E1 | |
| STGWFGGGFTSYLGF | 306 | Q96PC5 | |
| VRTAGWVGFGVTNRY | 61 | A6NHM9 | |
| SWAIGGLFGTAYTAG | 146 | Q96R54 | |
| RDGGFWYTGSHGSVC | 426 | O14926 | |
| GSSPWDRFLVGGYLS | 236 | Q96C03 | |
| SLSGTWTVYPNGRFG | 76 | P19526 | |
| TIGTFGFWAAYLAGG | 306 | P19526 | |
| GLGDGQFYSWTDGLR | 51 | Q49A17 | |
| SGFITAIYGAEWARG | 36 | P59535 | |
| WSRTGVFLFTASSGG | 96 | P08842 | |
| GTVAAGGYWAGLTEA | 196 | Q8IUH8 | |
| SGNWIEIAYGTSSGG | 391 | Q8TBC3 | |
| YGIGGLWRTSGQEAT | 1236 | Q9ULL8 | |
| YLLGFSTSTWEGTAG | 1151 | Q6P1J6 | |
| EAYINSGRTGWFGAF | 121 | A0A1W2PS18 | |
| TWSVDLAARGGGAYS | 1881 | Q99466 | |
| LGWTDTGFYRGVSRV | 121 | Q8NEG4 | |
| FRWFVQDYTGGGLGA | 181 | Q5GH73 | |
| TVIFAWAIGGEGFSY | 271 | Q6UVY6 | |
| WSAAAALGVYVGSGG | 26 | Q6PCB7 | |
| ALGVYVGSGGWRFLR | 31 | Q6PCB7 | |
| LLTARGGPSSWGYVS | 491 | Q9BXP2 | |
| LLAGGGFSTWTYRQG | 211 | Q93063 | |
| GYWSGGTSTGAAINF | 566 | Q6UXI7 | |
| LGYLLGSVAAFGSWA | 181 | Q2T9K0 | |
| AWGATIFSFGGAILY | 156 | Q9BQJ4 | |
| FSHWGRLTSYSGGGY | 256 | Q9P0L9 | |
| FSGIFWSSFVGGGVL | 126 | Q96CP7 | |
| AWGDGATGGLSVYAT | 456 | A2A288 | |
| TAIGTCFGYWLGVSS | 186 | Q9GZM5 | |
| GVLIGNWSGDYSRGT | 336 | P22735 | |
| GSAVIAFGLWFRFGG | 26 | O60636 | |
| VYFTGPGWEARGSFS | 226 | Q04206 | |
| WGVSPRGAGYLFGSD | 206 | P60510 | |
| GGWGNSDARYTPGSS | 1756 | Q8NDV7 |